Public Investment, Private Gain:
Canada’s Role in the mRNA Vaccine Breakthrough
Natalie Raffoul and Sarah Hamm
This case study examines Canada’s under-recognized yet foundational role in the development of the COVID-19 mRNA vaccines. Despite its substantial public investment in this technology, Canada failed to secure direct benefits or timely vaccine access for its citizens.
Public Investment, Private Gain:
Canada’s Role in the mRNA Vaccine Breakthrough Read More »










